EMA – European Medicines Agency organising workshop on biosimilars
The aim of this workshop is to bring together regulators and stakeholders to discuss the three draft revised guidelines, including comments received so far during the public consultation.
The workshop will be live-streamed and recorded.
The European Medicines Agency will invite stakeholders who provided comments on the draft guidelines to participate in the workshop. There will be a limited number of places available. Expressions of interest can be sent to email@example.com by 10 October 2013 using the registration form provided. Places available will be offered on a first-come-first-served basis.
Please click here for more information.